GAMCO Preferential Issue

GAMCO Earnings Call Transcript: Key Takeaways

H1 revenue ₹254 Cr (+79%) and PAT ₹38.5 Cr, but Q2 profit fell sharply from Q1 (₹6 Cr vs ₹32 Cr) and margins compressed. Growth leans on investment sales and debt-funded expansion, with no quantified guidance.

GAMCO Investor Presentation: Key Takeaways

Q2FY27 revenue Rs140.94 Cr (+61.67% YoY, +23.94% QoQ); EBITDA Rs12.16 Cr (8.65% margin); PAT Rs6.06 Cr (4.31% margin). Pivot to real estate, warehousing and hospitality.

GAMCO Management Change

GAMCO appointed Jayshri Tulsyan as Non-Executive Independent Director for 24 months, effective October 31, 2026. Ayushi Khaitan resigned as Non-Executive Non-Independent Director, citing personal reasons.

GAMCO Other Announcement

Gamco Ltd filed its half-yearly related party transactions disclosure under Regulation 23(9) for the period ended 30 September 2026. The filing is a periodic cumulative statement with no new transaction or board decision.

Execution

Half year ended 30 September 2026

GAMCO Preferential Issue

Gamco Limited's board constituted an Allotment Committee for its preferential issue on 31 October 2026. No amount or share count was disclosed in the filing.

GAMCO Q2 FY27 Results: Turns Profitable, Net Profit ₹6.1 Cr

GAMCO Ltd reported revenue from operations of ₹140.6 Cr (+61.8% YoY) and net profit of ₹6.1 Cr for Q2 FY27.

Key figure

Net profit ₹6.1 Cr

Kilburn Engineering Preferential Issue

Kilburn Engineering filed CARE Ratings' monitoring agency report for Q2 FY27 on its Rs 290.65 crore preferential issue. The report notes forfeited warrants and revised object allocations, with no deviation in objects.

Value

₹290.6 Cr

Highness Microelectronics Preferential Issue

Highness Microelectronics called an EGM for 4 December 2026 to approve a preferential issue of equity shares. Its sole item is a special resolution for the allotment.

Highness Microelectronics Preferential Issue

Highness Microelectronics calls a 4 December 2026 EGM to approve a preferential issue of 3,44,000 shares at Rs.315. The issue aggregates Rs.10.84 Crore from nine allottees.

Value

₹10.84 Cr

Aptus Pharma Preferential Issue

Aptus Pharma allotted 15,97,470 equity shares at ₹280 to 188 allottees, raising ₹44.73 Crore preferentially. Board approved the allotment on 12 November 2026.

Value

₹44.73 Cr

Kirloskar Electric Company Preferential Issue

KECL received BSE and NSE listing approvals for 34,68,007 preferential issue shares to Kirloskar Power Equipments Limited. The issue value is approximately ₹40 Crore.

Value

₹40.00 Cr

Yatharth Hospital & Trauma Care Services Preferential Issue

Yatharth Hospital received CCI approval for its proposed ₹3,150 Crore preferential issue to Rasmalai Limited (24.87% stake). This clears a key regulatory hurdle for the capital raise.

Value

₹3,150 Cr